BioSpace News Archive

With founding partner Equinox, Cycle for Survival surpasses $222 million raised since 2007; every dollar funds rare cancer research led by Memorial Sloan Kettering Cancer Center

Eighteen months after launching its revolutionary employer analytics and reporting solution, Blue Health Intelligence® is providing healthcare insights for millions of individuals who receive health benefits through their employers.

SynCardia continues commitment to invest in their executive leadership team

Workpath, a technology company that provides healthcare organizations with the tools and transparency to dispatch healthcare labor to patient homes or healthcare facilities, announced that it has integrated Lyft into its platform.

Gordian Surgical, a commercial-stage medical device company with growing international sales of its innovative TroClose™1200 access-closure system for laparoscopic (“lap”) surgery, today announced that it has surpassed 2,000 surgeries globally with its FDA-cleared and CE-marked TroClose1200 access-and-closure system for laparoscopic surgery.

As Life Time, the nation’s premier healthy lifestyle brand, continues to add to its health and wellness portfolio and high-end athletic lifestyle resorts, the company today announced the opening of Life Time Work West End, the first-of-its-kind in Minnesota—and second in the country (Life Time Work Ardmore opened in April 2018.)

We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product

Cato Research, LLC (CATO), a global provider of regulatory and clinical research services, announced today that its board of directors has appointed Mark Goldberg, M.D. to executive chairman, effective immediately

Kindbody, a new women’s healthcare company, announces a new program to enable self-insured employers to purchase fertility benefits direct

ADAM sets new milestone in medical technology by launching the 3D bioprinting of organic bone structures. ADAM has started passing the regulatory requirements to begin preclinical trials this month.